This study aimed to evaluate the effect of hip reconstruction on patients with skeletal metastases to the hip. We investigated the effect of hip reconstruction on quality of life and ambulatory status, as well as cost-effectiveness of hip reconstruction in this group of patients.
Get full access to this article
View all access options for this article.
References
1.
BauerH.C.Controversies in the surgical management of skeletal metastases.J Bone Joint Surg Br2005; 87(5): 608–617.
2.
HageW.D., AboulafiaA.J., AboulafiaD.M.Incidence, location, and diagnostic evaluation of metastatic bone disease.Orthop Clin North Am2000; 31(4): 515–528, vii.
3.
BickelsJ., DadiaS., LidarZ.Surgical management of metastatic bone disease.J Bone Joint Surg Am2009; 91(6): 1503–1516.
4.
SavageP.D., WardW.G.Medical management of metastatic skeletal disease.Orthop Clin North Am2000; 31(4): 545–555.
5.
CummingD., CummingJ., VinceA.Metastatic bone disease: the requirement for improvement in a multidisciplinary approach.Int Orthop2009; 33(2): 493–496.
6.
MalviyaA., GerrandC.Evidence for orthopaedic surgery in the treatment of metastatic bone disease of the extremities: a review article.Palliat Med2012; 26(6): 788–796.
7.
DeleaT., LangerC., McKiernanJ.The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer.Oncology2004; 67(5-6): 390–396.
8.
HarringtonK.D.The management of acetabular insufficiency secondary to metastatic malignant disease.J Bone Joint Surg1981; 63(4): 653–664.
OkenM.M., CreechR.H., TormeyD.C.Toxicity and response criteria of the Eastern Cooperative Oncology Group.Am J Clin Oncol1982; 5(6): 649–655.
11.
ChiaS.K., SpeersC.H., D'yachkovaY.The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer.Cancer2007; 110(5): 973–979.
12.
RyanC.J., ElkinE.P., CowanJ.Initial treatment patterns and outcome of contemporary prostate cancer patients with bone metastases at initial presentation.Cancer2007; 110(1): 81–86.
13.
RougraffB.Indications for operative treatment.Orthop Clin North Am2000; 31(4): 567–575, viii.
14.
NathanS.S., ChanL., TanW.L.The need for a system of prognostication in skeletal metastasis to decide best end-of-life care — a call to arms.Ann Acad Med Singapore2010; 39(6): 476–481.
15.
NathanS.S., HealeyJ.H., MellanoD.Survival in patients operated on for pathologic fracture: implications for end-of-life orthopedic care.J Clin Oncol2005; 23(25): 6072–6082.
16.
HansenB.H., KellerJ., LaitinenM.The Scandinavian Sarcoma Group Skeletal Metastasis Register. Survival after surgery for bone metastases in the pelvis and extremities.Acta Orthop Scand Suppl2004; 75(311): 11–15.
17.
BiermannJ.S., HoltG.E., LewisV.O.Metastatic bone disease: diagnosis, evaluation, and treatment.J Bone Joint Surg Am2009; 91(6): 1518–1530.
18.
BöhmP., HuberJ.The surgical treatment of bony metastases of the spine and limbs.J Bone Joint Surg Br2002; 84(4): 521–529.
19.
BremnerR.A., JelliffeA.M.The management of pathological fracture of the major long bones from metastatic cancer.J Bone Joint Surg Br1958; 40–B(4): 652–659.
20.
DouglassHOJr., ShuklaS.K., MindellE.Treatment of pathological fractures of long bones excluding those due to breast cancer.J Bone Joint Surg Am1976; 58(8): 1055–1061.
21.
PerezC.A., BradfieldJ.S., MorganH.C.Management of pathologic fractures.Cancer1972; 29(3): 684–693.
22.
SorensenJ.B., KleeM., PalshofT.Performance status assessment in cancer patients. An inter-observer variability study.Br J Cancer1993; 67(4): 773–775.
23.
OrrS.T., AisnerJ.Performance status assessment among oncology patients: a review.Cancer Treat Rep1986; 70(12): 1423–1429.
24.
ConillC., VergerE., SalameroM.Performance status assessment in cancer patients.Cancer1990; 65(8): 1864–1866.
25.
MarcoR.A., ShethD.S., BolandP.J.Functional and oncological outcome of acetabular reconstruction for the treatment of metastatic disease.J Bone Joint Surg Am2000; 82(5): 642–651.
26.
GhertM., AlsalehK., FarrokhyarF.Outcomes of an anatomically based approach to metastatic disease of the acetabulum.Clin Orthop Relat Res2007; 459: 122–127.
27.
KunisadaT., ChoongP.F.Major reconstruction for periacetabu-lar metastasis: early complications and outcome following surgical treatment in 40 hips.Acta Orthop Scand2000; 71(6): 585–590.
28.
AshfordR.U., HannaS.A., ParkD.H.Proximal femoral replacements for metastatic bone disease: financial implications for sarcoma units.Int Orthop2010; 34(5): 709–713.
29.
BengA.K., FongC.W., ShumE.Where the elderly die: the influence of socio-demographic factors and cause of death on people dying at home.Ann Acad Med Singapore2009; 38(8): 676–683.
30.
HongC.Y., ChowK.Y., PouloseJ.Place of death and its determinants for patients with cancer in Singapore: an analysis of data from the Singapore Cancer Registry, 2000–2009.J Palliat Med2011; 14(10): 1128–1134.
